MiR-662 is associated with metastatic relapse in early-stage breast cancer and promotes metastasis by stimulating cancer cell stemness

Margherita Puppo, Philippe Clézardin, Emmanuelle Charafe‐Jauffret et al.|British Journal of Cancer|2023

Cited by 8